In chronic myeloid leukemia patients on second-line...

BMC Cancer 2016 / 12 Vol. 16; Iss. 1

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants

Soverini, Simona, De Benedittis, Caterina, Castagnetti, Fausto, Gugliotta, Gabriele, Mancini, Manuela, Bavaro, Luana, Machova Polakova, Katerina, Linhartova, Jana, Iurlo, Alessandra, Russo, Domenico,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-016-2635-0
Date:
December, 2016
File:
PDF, 839 KB
english, 2016
Conversion to is in progress
Conversion to is failed